Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Activation of autophagy in mesenchymal stem cells provides tumor stromal support.

Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS, Pochampally RR.

Carcinogenesis. 2011 Jul;32(7):964-72. doi: 10.1093/carcin/bgr029. Epub 2011 Feb 11.

2.

Human mesenchymal stem cells enhance autophagy of lung carcinoma cells against apoptosis during serum deprivation.

Zhang MH, Hu YD, Xu Y, Xiao Y, Luo Y, Song ZC, Zhou J.

Int J Oncol. 2013 Apr;42(4):1390-8. doi: 10.3892/ijo.2013.1810. Epub 2013 Feb 6.

PMID:
23403920
3.

Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication.

Vallabhaneni KC, Hassler MY, Abraham A, Whitt J, Mo YY, Atfi A, Pochampally R.

PLoS One. 2016 Nov 3;11(11):e0166027. doi: 10.1371/journal.pone.0166027. eCollection 2016.

4.

Epigenetic reprogramming of IGF1 and leptin genes by serum deprivation in multipotential mesenchymal stromal cells.

Sanchez C, Oskowitz A, Pochampally RR.

Stem Cells. 2009 Feb;27(2):375-82. doi: 10.1634/stemcells.2008-0546.

5.

Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.

Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, Wang C, Pavlides S, Martinez-Cantarin MP, Capozza F, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Caro J, Lisanti MP, Sotgia F.

Cell Cycle. 2010 Sep 1;9(17):3515-33. Epub 2010 Sep 9.

6.

Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway.

Zhang Q, Yang YJ, Wang H, Dong QT, Wang TJ, Qian HY, Xu H.

Stem Cells Dev. 2012 May 20;21(8):1321-32. doi: 10.1089/scd.2011.0684. Epub 2012 Mar 28.

7.

Attenuating Hypoxia-Induced Apoptosis and Autophagy of Mesenchymal Stem Cells: the Potential of Sitagliptin in Stem Cell-Based Therapy.

Wang XM, Yang YJ, Wu YJ, Zhang Q, Qian HY.

Cell Physiol Biochem. 2015;37(5):1914-26. doi: 10.1159/000438552. Epub 2015 Nov 17.

8.

Autophagy promotes apoptosis of mesenchymal stem cells under inflammatory microenvironment.

Dang S, Yu ZM, Zhang CY, Zheng J, Li KL, Wu Y, Qian LL, Yang ZY, Li XR, Zhang Y, Wang RX.

Stem Cell Res Ther. 2015 Dec 15;6:247. doi: 10.1186/s13287-015-0245-4.

9.

Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition.

Bianchi G, Morandi F, Cilli M, Daga A, Bocelli-Tyndall C, Gambini C, Pistoia V, Raffaghello L.

PLoS One. 2012;7(10):e48654. doi: 10.1371/journal.pone.0048654. Epub 2012 Oct 31.

10.

Human mesenchymal stem cells/multipotent stromal cells consume accumulated autophagosomes early in differentiation.

Nuschke A, Rodrigues M, Stolz DB, Chu CT, Griffith L, Wells A.

Stem Cell Res Ther. 2014 Dec 17;5(6):140. doi: 10.1186/scrt530.

11.

Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic.

Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R.

Stem Cell Res. 2011 May;6(3):215-25. doi: 10.1016/j.scr.2011.01.004. Epub 2011 Jan 31.

13.

let-7b suppresses apoptosis and autophagy of human mesenchymal stem cells transplanted into ischemia/reperfusion injured heart 7by targeting caspase-3.

Ham O, Lee SY, Lee CY, Park JH, Lee J, Seo HH, Cha MJ, Choi E, Kim S, Hwang KC.

Stem Cell Res Ther. 2015 Aug 22;6:147. doi: 10.1186/s13287-015-0134-x.

14.

Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites.

Vallabhaneni KC, Penfornis P, Dhule S, Guillonneau F, Adams KV, Mo YY, Xu R, Liu Y, Watabe K, Vemuri MC, Pochampally R.

Oncotarget. 2015 Mar 10;6(7):4953-67.

15.

Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells.

Eiró N, Sendon-Lago J, Seoane S, Bermúdez MA, Lamelas ML, Garcia-Caballero T, Schneider J, Perez-Fernandez R, Vizoso FJ.

Oncotarget. 2014 Nov 15;5(21):10692-708.

16.

Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer.

Dembinski JL, Wilson SM, Spaeth EL, Studeny M, Zompetta C, Samudio I, Roby K, Andreeff M, Marini FC.

Cytotherapy. 2013 Jan;15(1):20-32. doi: 10.1016/j.jcyt.2012.10.003.

17.

Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.

Eliopoulos N, Zhao J, Bouchentouf M, Forner K, Birman E, Yuan S, Boivin MN, Martineau D.

Am J Physiol Renal Physiol. 2010 Dec;299(6):F1288-98. doi: 10.1152/ajprenal.00671.2009. Epub 2010 Sep 15.

18.

Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization.

Suzuki K, Sun R, Origuchi M, Kanehira M, Takahata T, Itoh J, Umezawa A, Kijima H, Fukuda S, Saijo Y.

Mol Med. 2011;17(7-8):579-87. doi: 10.2119/molmed.2010.00157. Epub 2011 Mar 11.

19.

Mesenchymal stem cells regulate the proliferation of T cells via the growth-related oncogene/CXC chemokine receptor, CXCR2.

Lee YS, Won KJ, Park SW, Lee HW, Kim B, Kim JH, Kim DK.

Cell Immunol. 2012 Sep;279(1):1-11. doi: 10.1016/j.cellimm.2012.08.002. Epub 2012 Sep 5.

PMID:
23023221
20.

Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.

Chiavarina B, Whitaker-Menezes D, Martinez-Outschoorn UE, Witkiewicz AK, Birbe R, Howell A, Pestell RG, Smith J, Daniel R, Sotgia F, Lisanti MP.

Cancer Biol Ther. 2011 Dec 15;12(12):1101-13. doi: 10.4161/cbt.12.12.18703. Epub 2011 Dec 15.

Supplemental Content

Support Center